Literature DB >> 6650280

Clinical efficacy of lentinan on neoplastic diseases.

T Taguchi, H Furue, T Kimura, T Kondo, T Hattori, N Ogawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6650280     DOI： 10.1007/978-1-4757-1410-4_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  3 in total

1.  Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.

Authors:  V Vetvicka; B P Thornton; G D Ross
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Structural characterisation and biological activities of a unique type beta-D-glucan obtained from Aureobasidium pullulans.

Authors:  Rui Tada; Asuka Tanioka; Haruyo Iwasawa; Kumi Hatashima; Yoshikazu Shoji; Ken-ichi Ishibashi; Yoshiyuki Adachi; Masatoshi Yamazaki; Kazufumi Tsubaki; Naohito Ohno
Journal:  Glycoconj J       Date:  2008-06-28       Impact factor: 2.916

3.  Euglena gracilis Z and its carbohydrate storage substance relieve arthritis symptoms by modulating Th17 immunity.

Authors:  Kengo Suzuki; Ayaka Nakashima; Masaharu Igarashi; Keita Saito; Makoto Konno; Noriyuki Yamazaki; Hiroaki Takimoto
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.